beta-lactams has been researched along with sq-23377 in 1 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (sq-23377) | Trials (sq-23377) | Recent Studies (post-2010) (sq-23377) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 4,385 | 10 | 493 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakizaki, S; Mori, M; Sato, K; Sato, N; Shimizu, H; Takagi, H; Takahashi, H; Takayama, H; Tsutiya, T | 1 |
1 other study(ies) available for beta-lactams and sq-23377
| Article | Year |
|---|---|
Faropenem enhances superoxide anion production by human neutrophils in vitro.
Topics: Anti-Bacterial Agents; beta-Lactams; Calcium; Dose-Response Relationship, Drug; Firefly Luciferin; Humans; Ionomycin; Lactams; Luminescent Measurements; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Superoxides; Time Factors | 1999 |